Clinical Trials

    Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 (HARMONi-7)

    Investigator: Jun Zhang

    Study Coordinator: Nicole Barrios

    Status: Enrolling

    ClinicalTrials.gov Number: NCT06767514

    Phone: 713.441.5607

    Protocol Number: PRO00040430

    Description


    Clinical study of ivonescimab for first-line treatment of metastatic NSCLC patients with high PD-L1. Evaluating overall survival and progression free survival.